JPMorgan Checks In On Myriad Genetics Following 30% Rally By: Benzinga via Benzinga June 29, 2017 at 15:06 PM EDT Myriad Genetics, Inc.'s (NASDAQ: MYGN) strong run has caught investors attentions, however, JPMorgan analyst Tycho Peterson still ... Read More >> Related Stocks: Myriad Genetics Inc